Bone histomorphometry in children prior to commencing renal replacement therapy

Pediatric Nephrology

Volumn 23, Issue 9, 2008, Pages 1523-1529

  Waller, Simon ^a   Shroff, Rukshana ^b   Freemont, Anthony J ^c   Rees, Lesley ^b  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bone biopsy; Chronic kidney disease; Growth; Histomorphometry; Parathyroid hormone; Renal osteodystrophy

Indexed keywords

ALFACALCIDOL; CALCIUM; FERROUS SULFATE; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; TETRACYCLINE;

ADOLESCENT; ARTICLE; BIOCHEMISTRY; BONE BIOPSY; BONE GROWTH; BONE MINERALIZATION; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; LOW DRUG DOSE; MALE; NORMAL VALUE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RENAL REPLACEMENT THERAPY;

ADOLESCENT; BONE AND BONES; BONE REMODELING; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; PARATHYROID HORMONE; RENAL OSTEODYSTROPHY; RENAL REPLACEMENT THERAPY;

EID: 47749100811     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0838-6     Document Type: Article

References (35)

1. Block GA, Cunningham J (2006) Morbidity and mortality associated with abnormalities in bone and mineral metabolism in CKD. In: Olgaard K (ed) Clinical guideline to the basics of bone and mineral metabolism in CKD. 1st edn. National Kidney Foundation, New York, pp 77-92
2. Hodson EM, Evans RA, Dunstan CR, Hills EE, Shaw PF (1982) Quantitative bone histology in children with chronic renal failure. Kidney Int 21(6):833-839
3. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, Gokal R (1993) Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 44(5):1071-1077
4. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, de BE, Darias E, Gonzalez-Posada JM (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47(5):1434-1442
5. Mathias R, Salusky I, Harman W, Paredes A, Emans J, Segre G, Goodman W (1993) Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital. J Am Soc Nephrol 3(12):1938-1946
6. Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45(1):253-258
7. Rees L (2008) What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 23(2):179-184
8. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46(4):1160-1166
9. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53(1):205-211
10. Ziolkowska H, Paniczyk-Tomaszewska M, Debinski A, Polowiec Z, Sawicki A, Sieniawska M (2000) Bone biopsy results and serum bone turnover parameters in uremic children. Acta Paediatr 89(6):666-671
11. Yalcinkaya F, Ince E, Tumer N, Ensari A, Ozkaya N (2000) Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis. Pediatr Int 42(1):53-57
12. Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33(5):975-982
13. Rehman MT, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47(6):529-534
14. Parker CR, Freemont AJ, Blackwell PJ, Grainge MJ, Hosking DJ (1999) Cross-sectional analysis of renal transplantation osteoporosis. J Bone Miner Res 14(11):1943-1951
15. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2(6):595-610
16. Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM (2000) Normative data for iliac bone histomorphometry in growing children. Bone 26(2):103-109
17. Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69(11):1945-1953
18. Potter DE, Broyer M, Chantler C, Gruskin A, Holliday MA, Roche A, Scharer K, Thissen D (1978) Measurement of growth in children with renal insufficiency. Kidney Int 14(4):378-382
19. Cole TJ (2002) A chart to link child centiles of body mass index, weight and height. Eur J Clin Nutr 56(12):1194-1199
20. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P (2006) Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 70(2):345-350
21. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58(2):259-263
22. Martin KJ, Gonzalez EA (2001) The evolution of assays for parathyroid hormone. Curr Opin Nephrol Hypertens 10(5):569-574
23. Klaus G, Watson A, Edefonti A, Fischbach M, Ronnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schroder C, Zurowska A, Ekim M, European Pediatric Dialysis Working Group (EPDWG) (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21(2):151-159
24. NKF K/DOQI (2005) K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Accessed at http://www.kidney.org/professionals/KDOGI/guidelines-pedbone/index.htm
25. Waller S, Ledermann S, Trompeter R, van't Hoff W, Ridout D, Rees L (2003) Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol 18(12):1236-1241
26. Waller SC, Ridout D, Cantor T, Rees L (2005) Parathyroid hormone and growth in children with chronic renal failure. Kidney Int 67(6):2338-2345
27. Cansick J, Waller S, Ridout D, Rees L (2007) Growth and PTH in prepubertal children on long-term dialysis. Pediatr Nephrol 22(9):1349-1354
28. Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18(11):2996-3003
29. Baron R (1999) Anatomy and ultrastructure of bone. In: Favus M (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. 4th edn. Lippincott Williams and Wilkins, Philadelphia, pp 3-10
30. French CB, Genel M (1986) Pathophysiology of growth failure in chronic renal insufficiency. Kidney Int Suppl 19:S59-S64
31. Schmitt CP, Ardissino G, Testa S, Claris-Appiani A, Mehls O (2003) Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18(5):440-444
32. Watson AR, Kooh SW, Tam CS, Reilly BJ, Balfe JW, Vieth R (1988) Renal osteodystrophy in children on CAPD: A prospective trial of 1-alpha-hydroxycholecalciferol therapy. Child Nephrol Urol 9(4):220-227
33. Sanchez CP, Salusky IB, Kuizon BD, Abdella P, Juppner H, Goodman WG (1998) Growth of long bones in renal failure: Roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54(6):1879-1887
34. Brown AJ, Dusso A, Slatopolsky E (1999) Vitamin D. Am J Physiol 277(2 Pt 2):F157-F175
35. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P (1998) A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44(4):805-809